University of Minnesota Medical School, Division of Rheumatic and Autoimmune Diseases — Minneapolis, Minnesota

University of Minnesota Medical School, Division of Rheumatic and Autoimmune Diseases is a clinical research site located in Minneapolis, Minnesota, United States 55455.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Minnesota Medical School, Division of Rheumatic and Autoimmune Diseases has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Rheumatoid Arthritis (RA).

Sponsors: SecondWave Systems Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Minnesota Medical School, Division of Rheumatic and Autoimmune Diseases?

University of Minnesota Medical School, Division of Rheumatic and Autoimmune Diseases has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Minnesota Medical School, Division of Rheumatic and Autoimmune Diseases conducted?

University of Minnesota Medical School, Division of Rheumatic and Autoimmune Diseases has 1 clinical trials on record, with 1 currently active. Their work covers Rheumatoid Arthritis (RA).

Is University of Minnesota Medical School, Division of Rheumatic and Autoimmune Diseases accredited by Crixeo Health?

University of Minnesota Medical School, Division of Rheumatic and Autoimmune Diseases has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Minnesota Medical School, Division of Rheumatic and Autoimmune Diseases?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.